Gabriel S Morris is CFO of Immix Biopharma, Inc.. Currently has a direct ownership of 290,659 shares of IMMX, which is worth approximately $1.22 Million. The most recent transaction as insider was on Sep 16, 2025, when has been sold 2,600 shares (Common Stock) at a price of $1.97 per share, resulting in proceeds of $5,122. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 291K
0.9% 3M change
1.69% 12M change
Total Value Held $1.22 Million

Gabriel S Morris Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 16 2025
BUY
Open market or private purchase
$5,122 $1.97 p/Share
2,600 Added 0.89%
290,659 Common Stock
Jun 18 2025
BUY
Open market or private purchase
$5,073 $2.28 p/Share
2,225 Added 0.77%
288,059 Common Stock
Jun 07 2024
BUY
Open market or private purchase
$5,300 $2.12 p/Share
2,500 Added 0.87%
285,834 Common Stock
Jun 04 2024
BUY
Open market or private purchase
$5,973 $1.81 p/Share
3,300 Added 1.15%
283,334 Common Stock
May 20 2024
BUY
Grant, award, or other acquisition
-
194,218 Added 40.95%
280,034 Common Stock
May 14 2024
BUY
Open market or private purchase
$10,035 $2.23 p/Share
4,500 Added 4.98%
85,816 Common Stock
Nov 14 2022
BUY
Open market or private purchase
$4,888 $0.94 p/Share
5,200 Added 6.01%
81,316 Common Stock
Dec 20 2021
BUY
Conversion of derivative security
$62,999 $0.85 p/Share
74,116 Added 50.0%
74,116 Common Stock
Dec 20 2021
BUY
Open market or private purchase
$10,000 $5.0 p/Share
2,000 Added 2.56%
76,116 Common Stock
GSM

Gabriel S Morris

CFO
Los Angeles, CA

Track Institutional and Insider Activities on IMMX

Follow Immix Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMMX shares.

Notify only if

Insider Trading

Get notified when an Immix Biopharma, Inc. insider buys or sells IMMX shares.

Notify only if

News

Receive news related to Immix Biopharma, Inc.

Track Activities on IMMX